TrialRespiratory research2021

Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial.

Jorge Maspero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.